Stroke and Systemic Embolism Prevention in Patients with Atrial Fibrillation in Belgium: Comparative Cost Effectiveness of New Oral Anticoagulants and Warfarin

被引：0
|
作者：
Thitima Kongnakorn
Tereza Lanitis
Lieven Annemans
Vincent Thijs
Marnix Goethals
Sophie Marbaix
Jean-Claude Wautrecht
机构：
[1] Evidera,Department of Neurology
[2] Ghent University (Ugent),Department of Vascular Diseases
[3] Brussels University (VUB),undefined
[4] University Hospital Leuven,undefined
[5] Mariaziekenhuis Noord-Limburg,undefined
[6] Pfizer NV/SA,undefined
[7] Hôpital Erasme - ULB,undefined
[8] Université Libre de Bruxelles,undefined
来源：
Clinical Drug Investigation | 2015年 / 35卷
关键词：
Warfarin; Dabigatran; Rivaroxaban; Apixaban; Efficiency Frontier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 119
页数：10
相关论文
共 50 条
  • [1] Stroke and Systemic Embolism Prevention in Patients with Atrial Fibrillation in Belgium: Comparative Cost Effectiveness of New Oral Anticoagulants and Warfarin
    Kongnakorn, Thitima
    Lanitis, Tereza
    Annemans, Lieven
    Thijs, Vincent
    Goethals, Marnix
    Marbaix, Sophie
    Wautrecht, Jean-Claude
    [J]. CLINICAL DRUG INVESTIGATION, 2015, 35 (02) : 109 - 119
  • [2] COMPARATIVE EFFICACY OF NEW ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION AMONG PATIENTS WITH PRIOR STROKE OR SYSTEMIC EMBOLISM
    Cope, S.
    Keen, A.
    Chen, M.
    Bergrath, E.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A105 - A105
  • [3] Comparison of the Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation in a UK Setting
    Zheng, Ying
    Sorensen, Sonja V.
    Gonschior, Ann-Katrin
    Noack, Herbert
    Heinrich-Nols, Jutta
    Sunderland, Tom
    Kansal, Anuraag R.
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (12) : 2015 - +
  • [4] Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation
    Kansal, Anuraag R.
    Zheng, Ying
    Pokora, Tiffany
    Sorensen, Sonja V.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 225 - 237
  • [5] New oral anticoagulants in stroke and systemic embolism prevention in patients suffering from atrial fibrillation
    Sleszycka, Justyna
    Demkow, Marcin
    [J]. POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2011, 7 (03): : 242 - 247
  • [6] COST-EFFECTIVENESS OF APIXABAN VERSUS OTHER NEW ORAL ANTICOAGULANTS AND WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN VENEZUELA
    Fernandez Avila, Y.
    Garcia, K. C.
    Garrido Lecca, S.
    Donato, B. M.
    Juarez-Garcia, A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A829 - A829
  • [7] Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand
    Ng, Siok Shen
    Nathisuwan, Surakit
    Phrommintikul, Arintaya
    Chaiyakunapruk, Nathorn
    [J]. THROMBOSIS RESEARCH, 2020, 185 : 63 - 71
  • [8] COST-EFFECTIVENESS OF WARFARIN CARE BUNDLES AND NOVEL ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION IN THAILAND
    Ng, S. S.
    Nathisuwan, S.
    Phrommintikul, A.
    Chaiyakunapruk, N.
    [J]. VALUE IN HEALTH, 2019, 22 : S551 - S551
  • [9] Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control
    Janzic, Andrej
    Kos, Mitja
    [J]. PHARMACOECONOMICS, 2015, 33 (04) : 395 - 408
  • [10] Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control
    Andrej Janzic
    Mitja Kos
    [J]. PharmacoEconomics, 2015, 33 : 395 - 408
12345